Overview

Hyperbaric Oxygen Treatment to Treat Mild Traumatic Brain Injury (mTBI)/Persistent Post-Concussion Syndrome (PPCS)

Status:
Unknown status

Trial end date:
2019-03-01

Target enrollment:

Participant gender:

Summary

Objective/Hypothesis: An eight-week course of forty low-pressure Hyperbaric Oxygen Treatment's (HBOT's) can significantly improve symptoms and cognitive function in subjects with the persistent-post concussion syndrome (PPCS) of mild traumatic brain injury (mTBI).

Phase:

Phase 3

Details

Lead Sponsor:

Louisiana State University Health Sciences Center in New Orleans

Collaborators:

U.S. Army Medical Research and Development Command
U.S. Army Medical Research and Materiel Command